LG Chem Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

LG Chem wird ein jährliches Gewinn- und Umsatzwachstum von 74.2% bzw. 11.8% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 88.6% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 7.6% betragen.

Wichtige Informationen

74.2%

Wachstumsrate der Gewinne

88.6%

EPS-Wachstumsrate

Chemicals Gewinnwachstum	65.7%
Wachstumsrate der Einnahmen	11.8%
Zukünftige Eigenkapitalrendite	7.6%
Analystenabdeckung	Good
Zuletzt aktualisiert	12 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

The LG Chem (KRX:051910) Share Price Has Gained 205%, So Why Not Pay It Some Attention?

Mar 19

Are LG Chem, Ltd.'s (KRX:051910) Mixed Financials Driving The Negative Sentiment?

Mar 01

What Is The Ownership Structure Like For LG Chem, Ltd. (KRX:051910)?

Feb 08

Are LG Chem's (KRX:051910) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Jan 04

The LG Chem (KRX:051910) Share Price Is Up 169% And Shareholders Are Boasting About It

Dec 17

Is Now The Time To Look At Buying LG Chem, Ltd. (KRX:051910)?

Nov 29

Gewinn- und Umsatzwachstumsprognosen

KOSE:A051910 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (KRW Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	67,101,039	3,131,922	-878,088	9,165,332	26
12/31/2025	57,550,774	1,737,800	-5,081,725	7,112,495	28
12/31/2024	49,299,764	486,298	-5,307,809	7,015,121	25
6/30/2024	50,538,732	131,291	-7,332,884	7,005,572	N/A
3/31/2024	52,574,730	968,294	-6,272,235	7,486,859	N/A
12/31/2023	55,249,785	1,347,764	-5,574,479	7,536,462	N/A
9/30/2023	55,771,153	1,304,749	-5,639,282	6,230,911	N/A
6/30/2023	56,260,949	1,533,717	-7,256,790	3,475,231	N/A
3/31/2023	53,672,738	1,579,739	-8,783,102	917,041	N/A
12/31/2022	50,983,251	1,787,935	-7,979,802	569,880	N/A
9/30/2022	48,261,645	2,115,238	-7,412,183	422,192	N/A
6/30/2022	44,874,556	2,161,793	-4,793,161	2,424,499	N/A
3/31/2022	44,566,419	3,082,075	-2,309,956	4,599,748	N/A
12/31/2021	42,599,284	3,372,134	-392,553	5,509,816	N/A
9/30/2021	40,564,040	2,657,870	354,431	5,791,521	N/A
6/30/2021	37,469,595	2,491,978	1,811,456	6,876,181	N/A
3/31/2021	32,957,568	1,358,149	1,999,971	7,004,321	N/A
12/31/2020	30,058,872	413,984	198,631	5,840,832	N/A
9/30/2020	28,570,095	839,732	-528,195	5,442,283	N/A
6/30/2020	27,965,952	491,977	-2,548,863	3,849,601	N/A
3/31/2020	27,817,070	198,754	-4,335,307	2,379,608	N/A
12/31/2019	27,353,078	342,523	-3,349,316	3,121,101	N/A
9/30/2019	27,285,247	480,655	-4,140,882	2,093,239	N/A
6/30/2019	27,621,160	706,284	-2,838,312	2,897,084	N/A
3/31/2019	27,894,600	1,119,553	-2,295,993	2,732,628	N/A
12/31/2018	28,183,013	1,472,608	-2,202,030	2,124,969	N/A
9/30/2018	27,272,503	1,668,223	-1,485,145	2,389,703	N/A
6/30/2018	26,434,728	1,845,786	-1,286,143	2,120,173	N/A
3/31/2018	25,764,936	1,945,139	N/A	2,993,674	N/A
12/31/2017	25,698,014	1,945,280	N/A	3,180,748	N/A
9/30/2017	24,777,508	1,898,369	N/A	2,702,610	N/A
6/30/2017	23,434,703	1,673,017	N/A	2,249,197	N/A
3/31/2017	22,271,872	1,472,851	N/A	1,950,127	N/A
12/31/2016	20,659,296	1,281,124	N/A	2,516,697	N/A
9/30/2016	20,188,190	1,222,608	N/A	2,882,921	N/A
6/30/2016	20,311,661	1,277,420	N/A	3,029,652	N/A
3/31/2016	20,165,653	1,249,954	N/A	2,918,568	N/A
12/31/2015	20,206,583	1,152,987	N/A	3,172,130	N/A
9/30/2015	20,538,296	1,052,789	N/A	2,635,820	N/A
6/30/2015	21,024,495	944,729	N/A	2,599,472	N/A
3/31/2015	21,820,036	822,616	N/A	2,788,618	N/A
12/31/2014	22,577,830	867,924	N/A	1,994,425	N/A
9/30/2014	22,846,164	934,525	N/A	1,986,505	N/A
6/30/2014	23,047,348	1,043,963	N/A	1,671,751	N/A
12/31/2013	23,143,612	1,265,968	N/A	2,182,884	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: A051910Das prognostizierte Gewinnwachstum (74.2% pro Jahr) liegt über der Sparquote (2.7%).

Ertrag vs. Markt: A051910Die Erträge des Unternehmens (74.2% pro Jahr) werden voraussichtlich schneller wachsen als der Markt KR (28.6% pro Jahr).

Hohe Wachstumserträge: A051910Es wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: A051910Die Einnahmen des Unternehmens (11.8% pro Jahr) werden voraussichtlich schneller wachsen als der Markt KR (9.6% pro Jahr).

Hohe Wachstumseinnahmen: A051910Die Einnahmen des Unternehmens (11.8% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: A051910Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (7.6%).

LG Chem Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus EPS estimates fall by 13%

Price target decreased by 7.5% to ₩508,467

Consensus EPS estimates fall by 18%

Price target decreased by 7.2% to ₩775,500

Consensus EPS estimates fall by 11%

Price target decreased to ₩956,800

Recent updates

Consensus EPS estimates fall by 13%

Is LG Chem (KRX:051910) Using Too Much Debt?

LG Chem Finds Key to Suppress Thermal Runaway in Batteries

LG Chem (KRX:051910) Is Reinvesting At Lower Rates Of Return

New minor risk - Earnings quality

Getting In Cheap On LG Chem, Ltd. (KRX:051910) Might Be Difficult

LG Chem Adds Eco-Friendliness to Flame-Retardant Plastics

Price target decreased by 7.5% to ₩508,467

Does LG Chem (KRX:051910) Have A Healthy Balance Sheet?

LG Chem Company and AVEO Oncology Announce LG Chem's First Proprietary Anti-Cancer Compound Enters Phase 1 Clinical Study, Dosing Initiated in the U.S

Capital Allocation Trends At LG Chem (KRX:051910) Aren't Ideal

LG Chem's (KRX:051910) Soft Earnings Are Actually Better Than They Appear

High number of new directors

Why Investors Shouldn't Be Surprised By LG Chem, Ltd.'s (KRX:051910) P/E

Why LG Chem, Ltd. (KRX:051910) Could Be Worth Watching

We Think LG Chem (KRX:051910) Is Taking Some Risk With Its Debt

Full year 2023 earnings: EPS and revenues miss analyst expectations

LG Chem, Ltd., Annual General Meeting, Mar 25, 2024

Consensus EPS estimates fall by 18%

Upcoming dividend of ₩10,000 per share at 2.0% yield

Investor sentiment improves as stock rises 17%

Price target decreased by 7.2% to ₩775,500

LG Chem and LX Hausys Develop Material Delays Battery Thermal Runaway Even At 1,500°C for 20 Minutes

Second quarter 2023 earnings released: EPS: ₩6,736 (vs ₩8,452 in 2Q 2022)

Consensus EPS estimates fall by 11%

LG Chem, Ltd. announced that it expects to receive KRW 1295 billion in funding

LG Chem Considering Ways to Lift Competitiveness of Petrochemical Business

First quarter 2023 earnings released: EPS: ₩6,059 (vs ₩8,838 in 1Q 2022)

Full year 2022 earnings: EPS and revenues miss analyst expectations

LG Chem, Ltd. (KOSE:A051910) completed the acquisition of AVEO Pharmaceuticals, Inc. (NasdaqCM:AVEO) from a group of shareholders.

Upcoming dividend of ₩12,000 per share

Third quarter 2022 earnings: EPS misses analyst expectations

Investor sentiment improved over the past week

LG Chem, Ltd. (KOSE:A051910) entered into a definitive agreement to acquire AVEO Pharmaceuticals, Inc. (NasdaqCM:AVEO) for approximately $520 million.

Now 23% undervalued

Now 22% undervalued

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

LG Chem Submits an IND Application to the US FDA for Its First Independent Global Phase 3 Clinical Trial of Its New Gout Drug Tigulixostat

First quarter 2022 earnings: Revenues exceed analyst expectations

LG Chem, Ltd. Develops Advanced Plastic Product to Prevent Thermal Runaway in EV Batteries

Investor sentiment improved over the past week

Full year 2021 earnings: EPS and revenues miss analyst expectations

Price target decreased to ₩956,800

Consensus EPS estimates fall by 11%

Now 22% undervalued after recent price drop

Now 25% undervalued after recent price drop

Upcoming dividend of ₩10,000 per share

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS ₩19,111 (vs ₩4,619 in 2Q 2020)

Consensus EPS estimates increase to ₩54,881

LG Chem Announces Topline Results of LC350189 From the Phase 2 Study (CLUE Study) Promising to Be a New Treatment Alternative With Improved Efficacy and Safety Profiles for Chronic Gout Patients

First quarter 2021 earnings released: EPS ₩12,560 (vs ₩449 in 1Q 2020)

At ₩920,000, Is It Time To Put LG Chem, Ltd. (KRX:051910) On Your Watch List?

Is LG Chem (KRX:051910) A Risky Investment?

Is LG Chem, Ltd. (KRX:051910) At Risk Of Cutting Its Dividend?

The LG Chem (KRX:051910) Share Price Has Gained 205%, So Why Not Pay It Some Attention?

LG Chem, Ltd., Annual General Meeting, Mar 25, 2021

Are LG Chem, Ltd.'s (KRX:051910) Mixed Financials Driving The Negative Sentiment?

Price target raised to ₩1,183,345

What Is The Ownership Structure Like For LG Chem, Ltd. (KRX:051910)?

New 90-day high: ₩1,028,000

Price target raised to ₩1,082,655

Price target raised to ₩1,007,828

Are LG Chem's (KRX:051910) Statutory Earnings A Good Reflection Of Its Earnings Potential?

New 90-day high: ₩889,000

The LG Chem (KRX:051910) Share Price Is Up 169% And Shareholders Are Boasting About It

Is Now The Time To Look At Buying LG Chem, Ltd. (KRX:051910)?

New 90-day high: ₩799,000

Third quarter 2020 earnings released: EPS ₩6,041